0001282304-12-000001.txt : 20121226 0001282304-12-000001.hdr.sgml : 20121226 20121226174630 ACCESSION NUMBER: 0001282304-12-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121218 FILED AS OF DATE: 20121226 DATE AS OF CHANGE: 20121226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KERSTEN GEERT R CENTRAL INDEX KEY: 0001236030 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11889 FILM NUMBER: 121285958 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CEL SCI CORP CENTRAL INDEX KEY: 0000725363 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 840916344 STATE OF INCORPORATION: CO FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 8229 BOONE BLVD . STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 BUSINESS PHONE: 7035069460 MAIL ADDRESS: STREET 1: 8229 BOONE BLVD. STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 FORMER COMPANY: FORMER CONFORMED NAME: INTERLEUKIN 2 INC DATE OF NAME CHANGE: 19880317 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2012-12-18 0 0000725363 CEL SCI CORP cvm 0001236030 KERSTEN GEERT R 1 1 0 0 Chief Executive Officer Options 0.28 2012-12-18 4 A 0 2300000 0 A 2013-12-18 2022-12-17 Common Stock 2300000 13283009 D Options 0.28 2012-12-18 4 A 0 2700000 0 A 2022-12-17 Common Stock 2700000 15983009 D Options 0.22 2012-12-18 4 D 0 1890000 0 D 2004-04-01 2013-04-01 Common Stock 1890000 14093009 D Options 0.28 2012-12-18 4 A 0 1890000 0 A 2012-12-18 2017-12-17 Common Stock 1890000 15983009 D Equally and annually over 5 years Shares Exercisable Date 110,770 12-18-13 110,770 12-18-14 354,090 12-18-15 354,085 12-18-16 354,085 12-18-17 354,085 12-18-18 354,085 12-18-19 354,085 12-18-20 354,085 12-18-21 Replacement of cancelled options at higher exercise price in return for extended expiration date Geert Kersten 2012-12-26